Investors & shareholders

Analysts coverage

Home » Investors & shareholders » Analysts coverage

Analysts coverage



AnalystMonthRecommendationTarget Price (1)
BBVANov 2019Overweight3,80
JB Capital MarketsApr 2020Buy3,80
MirabaudApr 2020Hold1,70
CheuvreuxApr 2020Buy2,00
FidentiisMay 2020Hold1,50
GVC GaescoMay 2020Buy2,50
NorbolsaJune 2020Buy1,76
BPIJune 2020Underperform1,50
SantanderJuly 2020Buy3,10


(1) Euros per share



The 50% fall in the market and COVID-19 mark TUBACEX’s results

The sales figure for the first half of the year amounts to €282 M, down 12.8% on the same period last year, and the EBITDA stands at €19.8 M, 40.5% less. These figures are a far cry from TUBACEX’s prospects at the start of the year but, even in such an unfavorable environment as the present, the...

read more